Search results
Results from the WOW.Com Content Network
Jefferies downgraded Biogen Inc (NASDAQ:BIIB), citing the company’s tough setup. Leqembi (lecanemab) sales growth remains sluggish, falling below consensus projections through 2030. Challenges ...
There were concerns that the cost of new plaque-targeting Alzheimer's drugs could overwhelm the program's finances, which provide care for 60 million seniors. Leqembi is priced at about $26,500 ...
Leqembi's sales are projected to grow 13-fold to 56.5 billion yen ($361.28 million) in fiscal 2024 from the year ended in March, Eisai said in its annual results on Wednesday.
Lecanemab, sold under the brand name Leqembi, is a monoclonal antibody medication used for the treatment of Alzheimer's disease. [ 2 ] [ 4 ] Lecanemab is an amyloid beta -directed antibody. [ 2 ] It is given via intravenous infusion to patients with mild cognitive impairment or mild dementia. [ 2 ]
uShip, Inc. is an Austin, Texas-based Internet company that operates uShip.com, an online marketplace for shipping services. Individuals and businesses post items they need shipped in a variety of categories, including auto transport, boat shipping, moving services, and the transport of heavy industrial equipment.
Bay Shipbuilding Company (BSC) is a shipyard and dry dock company in Sturgeon Bay, Door County, Wisconsin.As of 2015, Bay Ships was a subsidiary of Fincantieri Marine Group and produces articulated tug and barges, OPA-90 compliant double hull tank ships and offshore support vessels. [1]
(Reuters) -Biogen's Alzheimer's drug, Leqembi, will do well in the market whether a competitor comes or not, a company executive said at the Goldman Sachs Global Healthcare Conference on Wednesday.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more